Insight DOA 6 Panel Urine Drug Test Kit

Overview Insight DOA 6 Panel Urine Drug Test Kit

The Insight DOA 6-Panel Urine Drug Test provides a rapid, at-home qualitative analysis for six common drug classes in urine samples. This immunochromatographic assay simultaneously detects tetrahydrocannabinol, amphetamine, barbiturates, benzodiazepines, cocaine, and opiates. Each package contains ten individually sealed, six-drug screening cassettes. Its user-friendly design offers quick, efficient results. **Intended Use:** Detecting the presence of drugs in urine specimens. **Product Details:** This comprehensive kit identifies THC, amphetamine, barbiturates, benzodiazepines, cocaine, and opiates. The kit includes a testing device, a disposable sample dropper, and instructions. It screens for marijuana (THC), opiates (OPI), cocaine (COC), amphetamine (AMP), barbiturates (BAR), and benzodiazepines (BZO). **Analytical Sensitivity:** THC - 50 ng/mL; COC - 300 ng/mL; OPI - 300 ng/mL; BZO - 300 ng/mL; AMP - 1000 ng/mL; BAR - 300 ng/mL. This highly sensitive assay detects drug molecules at concentrations as low as 50 ng/mL or above 1000 ng/mL. The kit is simple, convenient, and ideal for immediate on-site testing, requiring only a readily collected urine sample. Rapid results facilitate prompt diagnosis. **Instructions:** Bring the Insight DOA 6-Panel device to room temperature before use. Open the foil pouch, remove the device, applicator, and desiccant. Use immediately after opening. Place the device on a flat surface. Using the applicator, collect 0.5 mL of urine and dispense it dropwise into the sample well (S), or use a micropipette to add 500 μL. Time the test; read results after 5 minutes. A negative result shows two pink bands (control (C) and test (T) regions); a positive result shows one pink band (only in the C region). An invalid result shows no bands. Do not interpret results beyond 8 minutes. Faint test lines indicate drug concentrations near the cutoff; retest or use a confirmatory method. **Safety Precautions:** Store in a cool, dry place. Read all instructions before use. Keep out of reach of children. For single use only.

How to Use Insight DOA 6 Panel Urine Drug Test Kit:

Allow the Insight DOA Panel 6.1 kit components to reach ambient temperature prior to analysis. Open an individual foil pouch by carefully tearing along the designated perforation. Retrieve the testing device, sample applicator, and desiccant packet. The test must be performed immediately following pouch opening. Position the device on a stable, level surface. Employ the supplied applicator to collect a urine sample, filling it to the 0.5 mL mark. Gently introduce the entire sample into the device's sample well (S), dropwise, minimizing air bubble incorporation. Alternatively, use a micropipette to carefully transfer 500 μl of urine to well (S). Initiate the timer and interpret results after 5 minutes in each test window. A negative result displays two pink bands in the control (C) and test (T) regions, indicating drug absence. A positive result shows one pink band in the control (C) region, signifying detectable drug presence. An invalid result occurs with the absence of bands in both (C) and (T) regions. Repeat the test with a new Insight DOA Panel 6.1 device after verifying procedure. Note: Results are unreliable beyond 8 minutes. A very pale band in the test region suggests the drug concentration approaches the assay's detection limit; retesting or confirmatory analysis is recommended before confirming a positive finding.

Safety Instruction of Insight DOA 6 Panel Urine Drug Test Kit:

• Keep in a clean, dry environment.
• Check the product label before using this medicine.
• Store away from young children.
• One-time use only.